Senthil Radhakrishnan, Ph.D.
Assistant Professor, Pathology, School of Medicine
PhD, University of Illinois at Chicago (2006)
MS, University of Illinois at Chicago (2002)
We are interested in understanding the cellular signaling pathways that are triggered in response to proteasome inhibitor drugs. We hope to devise new strategies to enhance the efficacy of proteasome inhibitors.
Autophagy,Cancer cell biology,Cell signaling,Drug discovery,Signal transduction,Targeted therapies